{
  "attach_pages": "3",
  "attach_size": "390",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP201810271223364145_1.pdf?1540734861000.pdf",
  "company_code": "80000204",
  "eitime": "2018-10-28 13:54:42",
  "extend": {},
  "info_code": "AP201810271223364145",
  "language": "0",
  "notice_date": "2018-10-28 00:00:00",
  "notice_title": "2018年第三季度报告点评：基本符合预期，投资收益或持续增厚业绩",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "C",
  "researcher": "周豫",
  "security": [
    {
      "market_uni": "0",
      "publish_relation": [
        {
          "originalCode": "727",
          "publishName": "医疗服务"
        }
      ],
      "short_name": "泰格医药",
      "short_name_ch": "泰格医药",
      "short_name_cht": "泰格醫藥",
      "short_name_en": "TIGERMED",
      "stock": "300347"
    }
  ],
  "short_name": "泰格医药",
  "source_sample_name": "川财证券"
}